113 related articles for article (PubMed ID: 37184243)
1. Revised structure model of norovirus-binding fucoidan from Undaria pinnatifida: oligofucose chains branch off from a β6-galactane.
Hanisch FG
Glycobiology; 2023 Aug; 33(7):556-566. PubMed ID: 37184243
[TBL] [Abstract][Full Text] [Related]
2. Fucoidan and Derived Oligo-Fucoses: Structural Features with Relevance in Competitive Inhibition of Gastrointestinal Norovirus Binding.
Hanisch FG; Aydogan C; Schroten H
Mar Drugs; 2021 Oct; 19(11):. PubMed ID: 34822462
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.
Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA
Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568
[TBL] [Abstract][Full Text] [Related]
4. Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models.
Burney M; Mathew L; Gaikwad A; Nugent EK; Gonzalez AO; Smith JA
Integr Cancer Ther; 2018 Sep; 17(3):755-761. PubMed ID: 29156992
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulating activities of low-molecular weight fuco-oligosaccharides prepared by enzymatic digestion of fucoidan from the sporophyll of Korean Undaria pinnatifida.
Kim WJ; Koo YK; Jung MK; Moon HR; Kim SM; Synytsya A; Yun-Choi HS; Kim YS; Park JK; Park YI
Arch Pharm Res; 2010 Jan; 33(1):125-31. PubMed ID: 20191353
[TBL] [Abstract][Full Text] [Related]
6. Novel Enzyme Actions for Sulphated Galactofucan Depolymerisation and a New Engineering Strategy for Molecular Stabilisation of Fucoidan Degrading Enzymes.
Cao HTT; Mikkelsen MD; Lezyk MJ; Bui LM; Tran VTT; Silchenko AS; Kusaykin MI; Pham TD; Truong BH; Holck J; Meyer AS
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30388774
[TBL] [Abstract][Full Text] [Related]
7. Biocatalysis of Fucodian in
Lee JM; Oh SY; Johnston TV; Ku S; Ji GE
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30769784
[TBL] [Abstract][Full Text] [Related]
8. An antithrombotic fucoidan, unlike heparin, does not prolong bleeding time in a murine arterial thrombosis model: a comparative study of Undaria pinnatifida sporophylls and Fucus vesiculosus.
Min SK; Kwon OC; Lee S; Park KH; Kim JK
Phytother Res; 2012 May; 26(5):752-7. PubMed ID: 22084059
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan Extracted from the New Zealand
Lu J; Shi KK; Chen S; Wang J; Hassouna A; White LN; Merien F; Xie M; Kong Q; Li J; Ying T; White WL; Nie S
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469516
[TBL] [Abstract][Full Text] [Related]
10. Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu).
Lee JB; Hayashi K; Hashimoto M; Nakano T; Hayashi T
Chem Pharm Bull (Tokyo); 2004 Sep; 52(9):1091-4. PubMed ID: 15340195
[TBL] [Abstract][Full Text] [Related]
11. Study of fucoidans as natural biomolecules for therapeutical applications in osteoarthritis.
Vaamonde-García C; Flórez-Fernández N; Torres MD; Lamas-Vázquez MJ; Blanco FJ; Domínguez H; Meijide-Faílde R
Carbohydr Polym; 2021 Apr; 258():117692. PubMed ID: 33593565
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of marine bacterial strain degrading fucoidan from Korean Undaria pinnatifida Sporophylls.
Kim WJ; Kim SM; Lee YH; Kim HG; Kim HK; Moon SH; Suh HH; Jang KH; Park YI
J Microbiol Biotechnol; 2008 Apr; 18(4):616-23. PubMed ID: 18467852
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro and in vivo antioxidant activities of commercial fucoidans from Macrocystis pyrifera, Undaria pinnatifida, and Fucus vesiculosus.
Silva MMCL; Dos Santos Lisboa L; Paiva WS; Batista LANC; Luchiari AC; Rocha HAO; Camara RBG
Int J Biol Macromol; 2022 Sep; 216():757-767. PubMed ID: 35870628
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida.
Alghazwi M; Smid S; Karpiniec S; Zhang W
Int J Biol Macromol; 2019 Feb; 122():255-264. PubMed ID: 30401646
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan Extracted from
Zhao Y; Zheng Y; Wang J; Ma S; Yu Y; White WL; Yang S; Yang F; Lu J
Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30205616
[TBL] [Abstract][Full Text] [Related]
16. Structure characterization and antioxidant activity of fucoidan isolated from Undaria pinnatifida grown in New Zealand.
Koh HSA; Lu J; Zhou W
Carbohydr Polym; 2019 May; 212():178-185. PubMed ID: 30832845
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand
Yang X; Wang S; Trangle SS; Li Y; White WL; Li J; Ying T; Kong Q; Zhao Y; Lu J
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30453677
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan from New Zealand Undaria pinnatifida: monthly variations and determination of antioxidant activities.
Mak W; Hamid N; Liu T; Lu J; White WL
Carbohydr Polym; 2013 Jun; 95(1):606-14. PubMed ID: 23618312
[TBL] [Abstract][Full Text] [Related]
19. Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza a Mouse Model.
Richards C; Williams NA; Fitton JH; Stringer DN; Karpiniec SS; Park AY
Mar Drugs; 2020 May; 18(5):. PubMed ID: 32397317
[TBL] [Abstract][Full Text] [Related]
20. Growth-inhibitory effect of a fucoidan from brown seaweed Undaria pinnatifida on Plasmodium parasites.
Chen JH; Lim JD; Sohn EH; Choi YS; Han ET
Parasitol Res; 2009 Jan; 104(2):245-50. PubMed ID: 18791738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]